FLT3 and acute myeloid leukemia: Patients with a high or low FLT3-ITD allelic ratio had similar outcomes after allogeneic HSCT, indicating the potential of an allogeneic HSCT to mitigate the adverse prognostic impact of a high FLT3-ITD allelic ratio in AML.